Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiromichi Wakui

Showing results (1-10 of 159) with videos related to

Pageof 16
Sort By:
Clinical and Experimental Nephrology|March 1, 2020
The pathophysiological role of angiotensin receptor-binding protein in hypertension and kidney diseases: Oshima Award Address 2019Hiromichi Wakui
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 28, 2012
[Physiology of novel AT1 receptor-binding molecule, ATRAP]Hiromichi Wakui, Kouichi Tamura
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 15, 2022
Impact of the COVID-19 pandemic on physical and psychological activities in elderly patients with hypertensionKengo Azushima, Hiromichi Wakui, Kouichi Tamura
Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 19, 2022
TRPC5 as a possible therapeutic target for vascular dysfunction associated with obesityHiromichi Wakui, Moe Ozawa, Kouichi Tamura
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|April 23, 2025
Three cases of anti-glomerular basement membrane antibody-associated rapidly progressive glomerulonephritis treated with plasma exchangeTomohiko Kanaoka, Hiromichi Wakui, Kouichi Tamura
Hypertension Research : Official Journal of the Japanese Society of Hypertension|December 24, 2024
Possible antihypertensive effects of mineralocorticoid receptor antagonists other than reducing extracellular waterRyutaro Morita, Hiromichi Wakui, Kouichi Tamura
Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 3, 2023
Metabolic dysfunction-associated fatty liver disease reflects a significantly higher risk of hypertension than non-alcoholic fatty liver diseaseTatsuki Uehara, Hiromichi Wakui, Kouichi Tamura
Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 8, 2023
Effects of Uric Acid-Lowering Therapy on the Kidney (HTR-2023-0096.R2)Shun-Ichiro Tsukamoto, Hiromichi Wakui, Kouichi Tamura
Hypertension Research : Official Journal of the Japanese Society of Hypertension|February 14, 2020
Mass clinical survey as a possible population strategy for the better control of hypertension in JapanKouichi Tamura, Takahiro Yamaji, Kengo Azushima, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 27, 2020
May need more comprehensive approach to residual risks in well controlled hypertensive patientsToru Suzuki, Daisuke Kamimura, Hiromichi Wakui, et al.
Pageof 16

Showing results (1-10 of 159) with videos related to

Sort By:
Pageof 16
Clinical and Experimental Nephrology|March 1, 2020
The pathophysiological role of angiotensin receptor-binding protein in hypertension and kidney diseases: Oshima Award Address 2019Hiromichi Wakui
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 28, 2012
[Physiology of novel AT1 receptor-binding molecule, ATRAP]Hiromichi Wakui, Kouichi Tamura
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 15, 2022
Impact of the COVID-19 pandemic on physical and psychological activities in elderly patients with hypertensionKengo Azushima, Hiromichi Wakui, Kouichi Tamura
Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 19, 2022
TRPC5 as a possible therapeutic target for vascular dysfunction associated with obesityHiromichi Wakui, Moe Ozawa, Kouichi Tamura
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|April 23, 2025
Three cases of anti-glomerular basement membrane antibody-associated rapidly progressive glomerulonephritis treated with plasma exchangeTomohiko Kanaoka, Hiromichi Wakui, Kouichi Tamura
Hypertension Research : Official Journal of the Japanese Society of Hypertension|December 24, 2024
Possible antihypertensive effects of mineralocorticoid receptor antagonists other than reducing extracellular waterRyutaro Morita, Hiromichi Wakui, Kouichi Tamura
Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 3, 2023
Metabolic dysfunction-associated fatty liver disease reflects a significantly higher risk of hypertension than non-alcoholic fatty liver diseaseTatsuki Uehara, Hiromichi Wakui, Kouichi Tamura
Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 8, 2023
Effects of Uric Acid-Lowering Therapy on the Kidney (HTR-2023-0096.R2)Shun-Ichiro Tsukamoto, Hiromichi Wakui, Kouichi Tamura
Hypertension Research : Official Journal of the Japanese Society of Hypertension|February 14, 2020
Mass clinical survey as a possible population strategy for the better control of hypertension in JapanKouichi Tamura, Takahiro Yamaji, Kengo Azushima, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 27, 2020
May need more comprehensive approach to residual risks in well controlled hypertensive patientsToru Suzuki, Daisuke Kamimura, Hiromichi Wakui, et al.
Pageof 16